# Pliant Therapeutics, Inc.: filings

PLRX · Nasdaq · CIK 1746473 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/plrx.md) · [Financials](/companies/plrx/financials.md) · [Filings](/companies/plrx/filings.md) · [Insiders](/companies/plrx/insiders.md)

## Reports and events: 104 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 189, 8-K 66, 3 25, SC 13G/A 21, 10-Q 19, SC 13G 15, SCHEDULE 13G/A 10, UPLOAD 8, CORRESP 7, S-8 7, 10-K 6, DEF 14A 6, DEFA14A 6, SCHEDULE 13G 6, 424B5 4, DRS/A 4, 144 3, DRSLTR 3, EFFECT 3, 10-K/A 2, 8-A12B 2, D 2, D/A 2, S-1/A 2, S-3ASR 2, 424B4 1, 4/A 1, 8-K/A 1, ARS 1, CERT 1, DRS 1, POS AM 1, POSASR 1, POS EX 1, PRE 14A 1, PRER14A 1, S-1 1, S-3 1, S-3MEF 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 20:10 ET | [8-K](/filings/0001746473-26-000115.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-26-000115 |
| 2026-08-11 | 20:08 ET | [10-Q](/filings/0001746473-26-000113.md) | Quarterly report, period 2026-06-30 | 0001746473-26-000113 |
| 2026-07-13 | 20:25 ET | [8-K](/filings/0001746473-26-000107.md) | 5.02 Departure or appointment of officers or directors | 0001746473-26-000107 |
| 2026-06-11 | 20:52 ET | [8-K](/filings/0001746473-26-000092.md) | 5.07 Shareholder vote results | 0001746473-26-000092 |
| 2026-05-11 | 20:10 ET | [10-Q](/filings/0001746473-26-000090.md) | Quarterly report, period 2026-03-31 | 0001746473-26-000090 |
| 2026-05-11 | 20:07 ET | [8-K](/filings/0001746473-26-000088.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-26-000088 |
| 2026-04-22 | 20:30 ET | [DEF 14A](/filings/0001746473-26-000076.md) | Proxy statement, period 2026-06-11 | 0001746473-26-000076 |
| 2026-04-17 | 20:30 ET | [8-K](/filings/0001746473-26-000050.md) | 5.02 Departure or appointment of officers or directors | 0001746473-26-000050 |
| 2026-03-30 | 21:38 ET | [8-K](/filings/0001746473-26-000046.md) | 8.01 Other events | 0001746473-26-000046 |
| 2026-03-11 | 20:31 ET | [8-K](/filings/0001746473-26-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-26-000039 |
| 2026-03-11 | 20:28 ET | [10-K](/filings/0001746473-26-000037.md) | Annual report, period 2025-12-31 | 0001746473-26-000037 |
| 2026-03-03 | 21:35 ET | [8-K](/filings/0001746473-26-000024.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001746473-26-000024 |
| 2025-12-16 | 22:05 ET | [8-K](/filings/0001746473-25-000182.md) | 5.02 Departure or appointment of officers or directors | 0001746473-25-000182 |
| 2025-12-08 | 21:41 ET | [8-K](/filings/0001746473-25-000179.md) | 5.02 Departure or appointment of officers or directors | 0001746473-25-000179 |
| 2025-11-06 | 21:20 ET | [10-Q](/filings/0001746473-25-000175.md) | Quarterly report, period 2025-09-30 | 0001746473-25-000175 |
| 2025-11-06 | 21:09 ET | [8-K](/filings/0001746473-25-000173.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-25-000173 |
| 2025-10-24 | 20:32 ET | [8-K](/filings/0001746473-25-000159.md) | 5.02 Departure or appointment of officers or directors | 0001746473-25-000159 |
| 2025-10-20 | 20:31 ET | [8-K](/filings/0001193125-25-243619.md) | 1.02 Termination of a material agreement | 0001193125-25-243619 |
| 2025-08-07 | 20:22 ET | [10-Q](/filings/0001746473-25-000150.md) | Quarterly report, period 2025-06-30 | 0001746473-25-000150 |
| 2025-08-07 | 20:16 ET | [8-K](/filings/0001746473-25-000149.md) | 9.01 Financial statements and exhibits | 0001746473-25-000149 |
| 2025-06-09 | 21:29 ET | [8-K](/filings/0001746473-25-000105.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001746473-25-000105 |
| 2025-05-08 | 20:16 ET | [10-Q](/filings/0001746473-25-000099.md) | Quarterly report, period 2025-03-31 | 0001746473-25-000099 |
| 2025-05-08 | 20:11 ET | [8-K](/filings/0001746473-25-000097.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-25-000097 |
| 2025-05-01 | 20:13 ET | [8-K](/filings/0001193125-25-109976.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors | 0001193125-25-109976 |
| 2025-04-23 | 20:17 ET | [DEF 14A](/filings/0001746473-25-000089.md) | Proxy statement, period 2025-06-05 | 0001746473-25-000089 |
| 2025-03-13 | 12:49 ET | [8-K](/filings/0001193125-25-053541.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-053541 |
| 2025-03-10 | 21:24 ET | [SCHEDULE 13D](/filings/0001214659-25-004133.md) | Ownership report, active investor | 0001214659-25-004133 |
| 2025-03-03 | 21:10 ET | [10-K](/filings/0001746473-25-000054.md) | Annual report, period 2024-12-31 | 0001746473-25-000054 |
| 2025-03-03 | 21:07 ET | [8-K](/filings/0001746473-25-000051.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-25-000051 |
| 2025-02-13 | 14:00 ET | [8-K](/filings/0001193125-25-025663.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-025663 |
| 2025-02-10 | 12:01 ET | [8-K](/filings/0001193125-25-023130.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-023130 |
| 2024-11-07 | 21:17 ET | [10-Q](/filings/0001746473-24-000171.md) | Quarterly report, period 2024-09-30 | 0001746473-24-000171 |
| 2024-11-07 | 21:14 ET | [8-K](/filings/0001746473-24-000169.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-24-000169 |
| 2024-09-27 | 20:11 ET | [8-K](/filings/0001746473-24-000153.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001746473-24-000153 |
| 2024-08-07 | 20:13 ET | [10-Q](/filings/0001746473-24-000145.md) | Quarterly report, period 2024-06-30 | 0001746473-24-000145 |
| 2024-08-07 | 20:08 ET | [8-K](/filings/0001746473-24-000143.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-24-000143 |
| 2024-07-15 | 15:54 ET | [8-K](/filings/0001193125-24-178937.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-178937 |
| 2024-06-14 | 20:04 ET | [8-K](/filings/0001746473-24-000084.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001746473-24-000084 |
| 2024-05-14 | 11:43 ET | [8-K](/filings/0001193125-24-137731.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-137731 |
| 2024-05-06 | 20:27 ET | [10-Q](/filings/0001746473-24-000076.md) | Quarterly report, period 2024-03-31 | 0001746473-24-000076 |
| 2024-05-06 | 20:11 ET | [8-K](/filings/0001746473-24-000073.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-24-000073 |
| 2024-04-22 | 20:58 ET | [DEF 14A](/filings/0001746473-24-000057.md) | Proxy statement, period 2023-12-31 | 0001746473-24-000057 |
| 2024-03-12 | 11:45 ET | [8-K](/filings/0001193125-24-065416.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-065416 |
| 2024-02-27 | 21:14 ET | [10-K](/filings/0001746473-24-000043.md) | Annual report, period 2023-12-31 | 0001746473-24-000043 |
| 2024-02-27 | 21:06 ET | [8-K](/filings/0001746473-24-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-24-000041 |
| 2024-02-05 | 12:31 ET | [8-K](/filings/0001193125-24-023459.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-023459 |
| 2023-11-09 | 21:15 ET | [10-Q](/filings/0001746473-23-000074.md) | Quarterly report, period 2023-09-30 | 0001746473-23-000074 |
| 2023-11-09 | 21:11 ET | [8-K](/filings/0001746473-23-000072.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-23-000072 |
| 2023-10-03 | 20:53 ET | [8-K](/filings/0001746473-23-000062.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001746473-23-000062 |
| 2023-09-26 | 11:34 ET | [8-K](/filings/0001193125-23-241849.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-241849 |

Page 1 of 3. [Older](/companies/plrx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.